BioProject

The emergence of multiresistance, pan-resistance, and "superbacteria" Klebsiella pneumoniae poses great challenges to anti-infection treatment. More...

The emergence of multiresistance, pan-resistance, and "superbacteria" Klebsiella pneumoniae poses great challenges to anti-infection treatment.Multiple drug-resistant bacteria have become a major clinical problem.CRKP carbaponella pneumoniae often carries other drug resistance genes, the resistance rate to commonly used clinical antimicrobial drugs is more than 60%, only sensitive to ticacycline, polymyxin, some aminoglycosides, so clinicians can choose antimicrobial drugs when treating infection is very limited.Our study was designed to explore the characteristics of clinical, microbiological, and molecular epidemiology of OXA-232-producing CRKP, and to provide the theoretical basis for controlling the transmission in the district. Less...